FR2389598A1 - - Google Patents

Info

Publication number
FR2389598A1
FR2389598A1 FR7713890A FR7713890A FR2389598A1 FR 2389598 A1 FR2389598 A1 FR 2389598A1 FR 7713890 A FR7713890 A FR 7713890A FR 7713890 A FR7713890 A FR 7713890A FR 2389598 A1 FR2389598 A1 FR 2389598A1
Authority
FR
France
Prior art keywords
glucagon
column
less
solution
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713890A
Other languages
English (en)
French (fr)
Other versions
FR2389598B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2389598A1 publication Critical patent/FR2389598A1/fr
Application granted granted Critical
Publication of FR2389598B1 publication Critical patent/FR2389598B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7713890A 1975-12-17 1977-05-06 Expired FR2389598B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/641,419 US4033941A (en) 1975-12-17 1975-12-17 Process for purifying glucagon

Publications (2)

Publication Number Publication Date
FR2389598A1 true FR2389598A1 (enExample) 1978-12-01
FR2389598B1 FR2389598B1 (enExample) 1981-06-19

Family

ID=24572291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713890A Expired FR2389598B1 (enExample) 1975-12-17 1977-05-06

Country Status (7)

Country Link
US (1) US4033941A (enExample)
CA (1) CA1089448A (enExample)
DE (1) DE2721027A1 (enExample)
FR (1) FR2389598B1 (enExample)
GB (1) GB1576344A (enExample)
NL (1) NL7703758A (enExample)
SE (1) SE443512B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
CA1284000C (en) * 1985-07-01 1991-05-07 David Gregory Maskalick Process for recovering glucagon from pancreas glands
WO2008015099A2 (en) 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
BRPI0717098B8 (pt) * 2006-09-22 2021-05-25 Novo Nordisk As análogos de insulina humana resistentes à protease, composição farmacêutica e processo para sua preparação
WO2008132224A2 (en) * 2007-04-30 2008-11-06 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
EP2164459A1 (en) * 2007-06-01 2010-03-24 Novo Nordisk A/S Stable non-aqueous pharmaceutical compositions
EP2254905B1 (en) * 2008-03-14 2016-12-14 Novo Nordisk A/S Protease-stabilized insulin analogues
PT2254906T (pt) 2008-03-18 2017-01-03 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
CN104364260B (zh) 2012-04-11 2017-02-22 诺和诺德股份有限公司 胰岛素制剂
MX366636B (es) 2013-10-07 2019-07-17 Novo Nordisk As Nuevo derivado de un análogo de insulina.
TWI700091B (zh) 2016-12-16 2020-08-01 丹麥商諾佛 儂迪克股份有限公司 含胰島素醫藥組成物
EP3517543B1 (en) 2018-01-30 2020-11-04 Bachem AG Manufacture of glucagon peptides
CN113024658B (zh) * 2019-12-25 2022-10-21 翰宇药业(武汉)有限公司 一种纯化利拉鲁肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
DE2258080C3 (de) * 1972-11-27 1981-12-17 Eli Lilly And Co., Indianapolis, Ind. Verfahren zur Gewinnung von Hexatriacontapeptiden
US3878186A (en) * 1973-05-09 1975-04-15 Lilly Co Eli Process for purifying insulin
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon

Also Published As

Publication number Publication date
US4033941A (en) 1977-07-05
GB1576344A (en) 1980-10-08
DE2721027A1 (de) 1978-11-16
SE7705162L (sv) 1978-11-04
FR2389598B1 (enExample) 1981-06-19
CA1089448A (en) 1980-11-11
NL7703758A (nl) 1978-10-09
SE443512B (sv) 1986-03-03

Similar Documents

Publication Publication Date Title
FR2389598A1 (enExample)
Yang Destruction of tryptophan during the aerobic oxidation of sulfite ions
Zakrzewski [68] Preparation of tritiated dihydrofolic acid of high specific activity
GB1445648A (en) Method of preparation of bromine from hydrobromic acid solutions
GB1439896A (en) Extraction of mercury values from gases
FR2414241A1 (fr) Generateur de radionucleides pour la separation des substances radioactives
ES284919A1 (es) Procedimiento para hacer potables las aguas salinas, reduciendo el contenido en sales de las mismas
FR2367119A1 (fr) Procede d'enrichissement de minerais d'ilmenite par reduction d'une liqueur de digestion
GB908333A (en) Method for the production of substantially protein-free callicrein
FR2424534A1 (fr) Appareil pour l'analyse automatique de melanges liquides ou gazeux par chromatographie en phase gazeuse
GB1129637A (en) Process for separating chlorine from phosgene
ES8402145A1 (es) Procedimiento para la obtencion de esencias aromatizantes enriquezidas.
SYUTO et al. Purification and crystallization of Clostridium botulinum type C toxin
ES479413A1 (es) Un procedimiento para la preparacion de una goma de xantano.
Bossa et al. Further microheterogeneity of cytoplasmic aspartate aminotransferase from pig heart
Butcher et al. Efficient translation and polyribosome binding of 125I‐labelled rabbit globin messenger ribonucleoprotein
BE1003262A6 (fr) Procede pour la separation selective d'iode par chromatographie a partir d'une solution aqueuse acide.
Weiss et al. Formation of lodinated Protein in Saliva
GB1459836A (en) Extraction of the active principle of fruit of synsepalum dulcificum
KR910003112A (ko) 에피데르민의 수득, 분리 및 정제방법
BE765310A (fr) Procede de separation et de concentration de l'etain de scories, concentres, etc., en contenant
GB1417078A (en) Treatment of dilute solutions of organo-lead ions to reduce the lead content thereof
ES428937A1 (es) Un procedimiento mejorado para la purificacion de acido sulfurico acuoso.
FR2450808A1 (fr) Procede de traitement d'amino-acide et application de l'amino-acide obtenu a titre de supplement alimentaire pour ruminants
GB1476439A (en) Nickel catalyst

Legal Events

Date Code Title Description
ST Notification of lapse